Exact Mass: 283.0433734
Exact Mass Matches: 283.0433734
Found 377 metabolites which its exact mass value is equals to given mass value 283.0433734,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Guanosine
Guanosine (G), also known as 2-amino-inosine, belongs to the class of organic compounds known as purine nucleosides. Purine nucleosides are compounds comprising a purine base attached to a ribosyl or deoxyribosyl sugar moiety. Guanosine consists of a guanine base attached to a ribose (ribofuranose) ring via a beta-N9-glycosidic bond. Guanosine is a white, crystalline powder with no odor and mild saline taste. It is very soluble in acetic acid, and slightly soluble in water, but insoluble in ethanol, diethyl ether, benzene, and chloroform. Guanosine exists in all living species, ranging from bacteria to plants to humans. High levels of guanosine can be found in clovers, coffee plants, and the pollen of pines. It has been detected, but not quantified in, several different foods, such as leeks, garlic, chicory roots, green bell peppers, and black-eyed peas. Guanosine plays an important role in various biochemical processes including the synthesis of nucleic acids such as RNA and intracellular signal transduction (cGMP). The antiviral drug acyclovir, often used in herpes treatment, and the anti-HIV drug abacavir, are both structurally similar to guanosine. Guanosine can be phosphorylated to become guanosine monophosphate (GMP), cyclic guanosine monophosphate (cGMP), guanosine diphosphate (GDP), and guanosine triphosphate (GTP). In humans, guanosine is involved in intracellular signalling through the adenosine receptors A1R and A2AR (PMID: 31847113). Evidence from rodent and cell models has shown a number of important neurotrophic and neuroprotective effects of guanosine. In particular, it is effective in preventing deleterious consequences of seizures, spinal cord injury, pain, mood disorders and aging-related diseases, such as ischemia, Parkinson‚Äôs and Alzheimer‚Äôs diseases (PMID: 27699087). Studies with rodent models of Parkinson‚Äôs disease have shown that guanosine decreases neuronal apoptotic cell death and increases dopaminergic neurons at substantia nigra pars compacta, accompanied by an improvement of motor symptoms in Parkinson‚Äôs disease (i.e. a reduction of bradykinesia). Guanosine promotes neurite arborization, outgrowth, proliferation and differentiation. Systemic administration of guanosine for eight weeks (8 mg/kg) has been shown to stimulate neuroprogenitors proliferation in the subventricular zone (SVZ) in a mouse model of Parkinsonism (PMID: 27699087). The effect of guanosine treatment is accompanied by an increased number of fibroblast growth factor (FGF-2)-positive cells which is an important regulator of neuroprogenitor/stem cell proliferation, survival and differentiation (PMID: 27699087). Guanosine prevents reactive oxygen species (ROS) generation and cell death in hippocampal slices subjected to the oxygen/glucose deprivation (PMID: 31847113). Guanosine is a purine nucleoside in which guanine is attached to ribofuranose via a beta-N(9)-glycosidic bond. It has a role as a fundamental metabolite. It is a purines D-ribonucleoside and a member of guanosines. It is functionally related to a guanine. Guanosine is a nucleoside comprising guanine attached to a ribose (ribofuranose) ring via a β-N9-glycosidic bond. Guanosine can be phosphorylated to become GMP (guanosine monophosphate), cGMP (cyclic guanosine monophosphate), GDP (guanosine diphosphate) and GTP (guanosine triphosphate) which are factors in signal transduction pathways. Guanosine is a metabolite found in or produced by Escherichia coli (strain K12, MG1655). Guanosine is a natural product found in Ulva australis, Allium chinense, and other organisms with data available. Guanosine is a purine nucleoside formed from a beta-N9-glycosidic bond between guanine and a ribose ring and is essential for metabolism. Guanosine is a metabolite found in or produced by Saccharomyces cerevisiae. A purine nucleoside that has guanine linked by its N9 nitrogen to the C1 carbon of ribose. It is a component of ribonucleic acid and its nucleotides play important roles in metabolism. (From Dorland, 28th ed) Guanosine is a nucleoside comprising guanine attached to a ribose (ribofuranose) ring via a beta-N9-glycosidic bond. Guanosine can be phosphorylated to become GMP (guanosine monophosphate), cGMP (cyclic guanosine monophosphate), GDP (guanosine diphosphate) and GTP (guanosine triphosphate). ; The nucleoside guanosine exert important neuroprotective and neuromodulator roles in the central nervous system, which may be related to inhibition of the glutamatergic neurotransmission activity. Guanosine is the specific extracellular guanine-based purines effector and indicate that its conversion occurs not only in the central nervous system but also peripherally. (PMID: 16325434); Guanosine is a nucleoside comprising guanine attached to a ribose (ribofuranose) ring via a ?-N9-glycosidic bond. Guanosine is found in many foods, some of which are elderberry, malus (crab apple), acerola, and arrowhead. A purine nucleoside in which guanine is attached to ribofuranose via a beta-N(9)-glycosidic bond. COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS [Spectral] Guanosine (exact mass = 283.09167) and 3,4-Dihydroxy-L-phenylalanine (exact mass = 197.06881) and Glutathione disulfide (exact mass = 612.15196) and AMP (exact mass = 347.06308) were not completely separated on HPLC under the present analytical conditions as described in AC$XXX. Additionally some of the peaks in this data contains dimers and other unidentified ions. [Spectral] Guanosine (exact mass = 283.09167) and Guanine (exact mass = 151.04941) and 3,4-Dihydroxy-L-phenylalanine (exact mass = 197.06881) were not completely separated on HPLC under the present analytical conditions as described in AC$XXX. Additionally some of the peaks in this data contains dimers and other unidentified ions. Acquisition and generation of the data is financially supported in part by CREST/JST. relative retention time with respect to 9-anthracene Carboxylic Acid is 0.125 CONFIDENCE standard compound; INTERNAL_ID 317 KEIO_ID G015; [MS2] KO008966 Annotation level-2 KEIO_ID G015 Guanosine (DL-Guanosine) is a purine nucleoside comprising guanine attached to a ribose (ribofuranose) ring via a β-N9-glycosidic bond. Guanosine possesses anti-HSV activity. Guanosine (DL-Guanosine) is a purine nucleoside comprising guanine attached to a ribose (ribofuranose) ring via a β-N9-glycosidic bond. Guanosine possesses anti-HSV activity. Guanosine (DL-Guanosine) is a purine nucleoside comprising guanine attached to a ribose (ribofuranose) ring via a β-N9-glycosidic bond. Guanosine possesses anti-HSV activity.
Crotonosid
C10H13N5O5 (283.09166480000005)
Crotonoside is a purine nucleoside. Crotonoside is a natural product found in Croton tiglium with data available. CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 26 Crotonoside is isolated from Chinese medicinal herb, Croton. Crotonoside inhibits FLT3 and HDAC3/6, exhibits selective inhibition in acute myeloid leukemia (AML) cells. Crotonoside could be a promising new lead compound for the research of AML[1]. Crotonoside is isolated from Chinese medicinal herb, Croton. Crotonoside inhibits FLT3 and HDAC3/6, exhibits selective inhibition in acute myeloid leukemia (AML) cells. Crotonoside could be a promising new lead compound for the research of AML[1]. Crotonoside is isolated from Chinese medicinal herb, Croton. Crotonoside inhibits FLT3 and HDAC3/6, exhibits selective inhibition in acute myeloid leukemia (AML) cells. Crotonoside could be a promising new lead compound for the research of AML[1].
Penconazole
CONFIDENCE standard compound; INTERNAL_ID 411; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9666; ORIGINAL_PRECURSOR_SCAN_NO 9664 CONFIDENCE standard compound; INTERNAL_ID 411; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9722; ORIGINAL_PRECURSOR_SCAN_NO 9721 CONFIDENCE standard compound; INTERNAL_ID 411; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9751; ORIGINAL_PRECURSOR_SCAN_NO 9750 CONFIDENCE standard compound; INTERNAL_ID 411; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9670; ORIGINAL_PRECURSOR_SCAN_NO 9668 CONFIDENCE standard compound; INTERNAL_ID 411; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9676; ORIGINAL_PRECURSOR_SCAN_NO 9675 CONFIDENCE standard compound; INTERNAL_ID 411; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9793; ORIGINAL_PRECURSOR_SCAN_NO 9792 CONFIDENCE standard compound; EAWAG_UCHEM_ID 3107 D016573 - Agrochemicals D010575 - Pesticides
Procymidone
C13H11Cl2NO2 (283.01668060000003)
CONFIDENCE standard compound; EAWAG_UCHEM_ID 3102 CONFIDENCE standard compound; INTERNAL_ID 8485 D016573 - Agrochemicals D010575 - Pesticides
Fosthiazate
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics D016573 - Agrochemicals D010575 - Pesticides CONFIDENCE standard compound; EAWAG_UCHEM_ID 3050 CONFIDENCE standard compound; INTERNAL_ID 463; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8295; ORIGINAL_PRECURSOR_SCAN_NO 8293 CONFIDENCE standard compound; INTERNAL_ID 463; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8351; ORIGINAL_PRECURSOR_SCAN_NO 8349 CONFIDENCE standard compound; INTERNAL_ID 463; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8336; ORIGINAL_PRECURSOR_SCAN_NO 8334 CONFIDENCE standard compound; INTERNAL_ID 463; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8335; ORIGINAL_PRECURSOR_SCAN_NO 8333 CONFIDENCE standard compound; INTERNAL_ID 463; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8296; ORIGINAL_PRECURSOR_SCAN_NO 8294 CONFIDENCE standard compound; INTERNAL_ID 463; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8249; ORIGINAL_PRECURSOR_SCAN_NO 8247
Risedronate
Risedronate is only found in individuals that have used or taken this drug. It is a bisphosphonate used to strengthen bone, treat or prevent osteoporosis, and treat Pagets disease of bone.The action of risedronate on bone tissue is based partly on its affinity for hydroxyapatite, which is part of the mineral matrix of bone. Risedronate also targets farnesyl pyrophosphate (FPP) synthase. Nitrogen-containing bisphosphonates (such as pamidronate, alendronate, risedronate, ibandronate and zoledronate) appear to act as analogues of isoprenoid diphosphate lipids, thereby inhibiting FPP synthase, an enzyme in the mevalonate pathway. Inhibition of this enzyme in osteoclasts prevents the biosynthesis of isoprenoid lipids (FPP and GGPP) that are essential for the post-translational farnesylation and geranylgeranylation of small GTPase signalling proteins. This activity inhibits osteoclast activity and reduces bone resorption and turnover. In postmenopausal women, it reduces the elevated rate of bone turnover, leading to, on average, a net gain in bone mass. M - Musculo-skeletal system > M05 - Drugs for treatment of bone diseases > M05B - Drugs affecting bone structure and mineralization > M05BA - Bisphosphonates C78281 - Agent Affecting Musculoskeletal System > C67439 - Bone Resorption Inhibitor D050071 - Bone Density Conservation Agents > D004164 - Diphosphonates D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators
Cucumopine
C11H13N3O6 (283.08043180000004)
Cucumopine, also known as mikimopine or cucumopine, (4r-cis)-isomer, is a member of the class of compounds known as L-alpha-amino acids. L-alpha-amino acids are alpha amino acids which have the L-configuration of the alpha-carbon atom. Cucumopine is slightly soluble (in water) and a moderately acidic compound (based on its pKa). Cucumopine can be found in carrot and wild carrot, which makes cucumopine a potential biomarker for the consumption of these food products.
N2-Acetyl-L-aminoadipyl-delta-phosphate
C8H14NO8P (283.04570140000004)
Avenanthramide 1p
Avenanthramide 1p is a polyphenol compound found in foods of plant origin (PMID: 20428313)
8-Hydroxy-deoxyguanosine
C10H13N5O5 (283.09166480000005)
8-hydroxy-deoxyguanosine (8-OHdG) is a sensitive marker of the DNA damage due to hydroxyl radical attack at the C8 of guanine. This damage, if left unrepaired, has been proposed to contribute to mutagenicity and cancer promotion. 8-OHdG has also been identified as a uremic toxin according to the European Uremic Toxin Working Group (PMID: 22626821). 8-hydroxy-deoxyguanosine (8-OHdG) is a sensitive marker of the DNA damage due to hydroxyl radical attack at the C8 of guanine. This damage, if left unrepaired, has been proposed to contribute to mutagenicity and cancer promotion. [HMDB] 8-Hydroxy-2'-deoxyguanosine is a critical biomarker of oxidative stress and carcinogenesis. 8-Hydroxy-2'-deoxyguanosine is a critical biomarker of oxidative stress and carcinogenesis.
(E)-Avenanthramide D
(E)-Avenanthramide D is found in cereals and cereal products. (E)-Avenanthramide D is isolated from the oat Avena sativa. Isolated from the oat Avena sativa. (E)-Avenanthramide D is found in oat and cereals and cereal products.
9-beta-d-Arabinofuranosylguanine
C10H13N5O5 (283.09166480000005)
8-Hydroxy-2-desoxyguanosine
C10H13N5O5 (283.09166480000005)
Deoxythioguanosine
C10H13N5O3S (283.07390680000003)
hydroxydeoxyguanosine
C10H13N5O5 (283.09166480000005)
1-[(2R,5R)-4-Azidooxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione
C10H13N5O5 (283.09166480000005)
2-Amino-9-[(2R,4S,5R)-5-(hydroperoxymethyl)-4-hydroxyoxolan-2-yl]-1H-purin-6-one
C10H13N5O5 (283.09166480000005)
3-methyl-N-phenyl-1-benzothiophene-2-carbothioamide
C16H13NS2 (283.04893780000003)
2-Amino-4-(4-methoxyphenyl)-1-methyl-1H-imidazole-5-sulfonic acid
8H-Benzo[b]pyrido[4,3,2-de][1,8]phenanthroline-8-one
8-oxo-2-Deoxyguanosine
C10H13N5O5 (283.09166480000005)
8-Hydroxy-2'-deoxyguanosine is a critical biomarker of oxidative stress and carcinogenesis. 8-Hydroxy-2'-deoxyguanosine is a critical biomarker of oxidative stress and carcinogenesis.
Guanosine
C10H13N5O5 (283.09166480000005)
MS2 deconvoluted using MS2Dec from all ion fragmentation data, MetaboLights identifier MTBLS1040; NYHBQMYGNKIUIF_STSL_0162_Guanosine_0500fmol_180430_S2_LC02_MS02_164; Spectrum acquired as described in Naz et al 2017 PMID 28641411. Preparation and submission to MassBank of North America by Chaleckis R. and Tada I. MS2 deconvoluted using CorrDec from all ion fragmentation data, MetaboLights identifier MTBLS1040; Spectrum acquired as described in Naz et al 2017 PMID 28641411. Preparation and submission to MassBank of North America by Chaleckis R. and Tada I. Spectrum acquired as described in Naz et al 2017 PMID 28641411. Preparation and submission to MassBank of North America by Chaleckis R. and Tada I.; MS2 deconvoluted using CorrDec from all ion fragmentation data, MetaboLights identifier MTBLS1040 Guanosine (DL-Guanosine) is a purine nucleoside comprising guanine attached to a ribose (ribofuranose) ring via a β-N9-glycosidic bond. Guanosine possesses anti-HSV activity. Guanosine (DL-Guanosine) is a purine nucleoside comprising guanine attached to a ribose (ribofuranose) ring via a β-N9-glycosidic bond. Guanosine possesses anti-HSV activity. Guanosine (DL-Guanosine) is a purine nucleoside comprising guanine attached to a ribose (ribofuranose) ring via a β-N9-glycosidic bond. Guanosine possesses anti-HSV activity.
Crotonoside
C10H13N5O5 (283.09166480000005)
Purines Crotonoside is isolated from Chinese medicinal herb, Croton. Crotonoside inhibits FLT3 and HDAC3/6, exhibits selective inhibition in acute myeloid leukemia (AML) cells. Crotonoside could be a promising new lead compound for the research of AML[1]. Crotonoside is isolated from Chinese medicinal herb, Croton. Crotonoside inhibits FLT3 and HDAC3/6, exhibits selective inhibition in acute myeloid leukemia (AML) cells. Crotonoside could be a promising new lead compound for the research of AML[1]. Crotonoside is isolated from Chinese medicinal herb, Croton. Crotonoside inhibits FLT3 and HDAC3/6, exhibits selective inhibition in acute myeloid leukemia (AML) cells. Crotonoside could be a promising new lead compound for the research of AML[1].
Penconazole
D016573 - Agrochemicals D010575 - Pesticides
5-Chloro-N-(1H-indol-5-yl)pyrazolo[1,5-a]pyrimidin-7-amine
2,6-Dimethyl-3-(2-propenyl)benzothiazolium bromide
3-[4-(PYRROLIDIN-1-YLSULFONYL)PHENYL]PROPANOIC ACID
8-METHYL-2-(5-METHYLTHIEN-2-YL)QUINOLINE-4-CARBOXYLIC ACID
C16H13NO2S (283.06669580000005)
ethyl 5,7-dichloro-2-methylquinoline-3-carboxylate
C13H11Cl2NO2 (283.01668060000003)
4-[(3-OXO-2,3-DIHYDRO-4H-1,4-BENZOXAZIN-4-YL)METHYL]BENZOIC ACID
2-Chloro-4-(morpholin-4-yl)thieno[2,3-d]pyrimidine-6-carboxaldehyde
C11H10ClN3O2S (283.01822300000003)
ethyl 4,6-dichloro-8-methylquinoline-3-carboxylate
C13H11Cl2NO2 (283.01668060000003)
6-Thio-2-Deoxyguanosine
C10H13N5O3S (283.07390680000003)
6-Thio-2'-Deoxyguanosine is a nucleoside analogue that can be incorporated into de novo-synthesized telomeres by telomerase.
3-AMINO-4(PHENYLSULFONYL)THIOPHENE-2-CARBOXYLIC ACID
METHYL 2-[[5-(TRIFLUOROMETHYL)-2-PYRIDYL]SULFONYL]ACETATE
2-[(2,2-diethoxyethyl)thio]-1,3-benzothiazole
C13H17NO2S2 (283.07006620000004)
3-[1-(3-chlorophenoxy)ethyl]-4-ethyl-1H-1,2,4-triazole-5-thione
5-(tert-Butoxycarbonyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine-2-carboxylic acid
6-CHLORO-N-(5-ETHOXY-1H-PYRAZOL-3-YL)-3-NITROPYRIDIN-2-AMINE
C10H10ClN5O3 (283.04721400000005)
2-BROMO-6-METHYL-5H-PYRROLO[2,3-B]PYRAZINE-7-CARBOXYLIC ACID ETHYL ESTER
2-Methyl-4-hydroxy-2H-1,2-benzothiazine-3-carboxylic acid ethyl ester 1,1-dioxide
4-methylsulfanyl-2-[(2-phenoxyacetyl)amino]butanoic acid
2-[[4-(TRIFLUOROMETHYL)PHENYL]SULPHONYL]ETHANETHIOAMIDE
L-Guanosine
C10H13N5O5 (283.09166480000005)
L-Guanosine is the L-configuration of Guanosine (HY-N0097). Guanosine is a purine nucleoside with anti-herpesvirus activity[1][2].
3-[(2,4-DICHLOROBENZYL)OXY]-2-METHYLPYRIDIN-4-OL
C13H11Cl2NO2 (283.01668060000003)
2-BROMO-4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIDINE
N-[2-oxo-4-(trifluoromethyl)chromen-7-yl]prop-2-enamide
4-ACETYLAMINO-NAPHTHALENE-1-SULFONYL CHLORIDE
C12H10ClNO3S (283.00699000000003)
3-Bromo-pyrrolidine-1-carboxylic acid benzyl ester
4-METHANESULFONYL-BIPHENYL-2-YLAMINE HYDROCHLORIDE
4-Bromobenzeneboronic acid N-methyldiethanolamine cyclic ester
3-Bromobenzeneboronic Acid N-Methyldiethanolamine Ester
(r)-3-amino-4-(3-trifluoromethylphenyl)butanoic acid hydrochloride
1-(4-CHLOROPHENYL)-1-(4-METHOXYPHENYL)METHYLAMINE HYDROCHLORIDE
1-(CHLOROACETYL)-4-(4-NITROPHENYL)PIPERAZINE
C12H14ClN3O3 (283.07236439999997)
6,8-dichloro-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline-4-carboxylic acid
C13H11Cl2NO2 (283.01668060000003)
N-[2-Amino-4-chloro-6-[[(1R,4S)-4-(hydroxymethyl)-2-cyclopenten-1-yl]amino]-5-pyrimidinyl]formamide
2-(4-Methoxybenzyloxy)-5-(trifluoromethyl)pyridine
(Z)-4-(4-CHLOROBENZYLIDENE)-2-PHENYLOXAZOL-5(4H)-ONE
(S)-3-AMINO-4-(3-(TRIFLUOROMETHYL)PHENYL)BUTANOIC ACID HYDROCHLORIDE
2-(4-NITRO-PHENYL)-3H-BENZOIMIDAZOLE-5-CARBOXYLIC ACID
2-(2-NITRO-PHENYL)-1H-BENZOIMIDAZOLE-5-CARBOXYLIC ACID
2-(4-nitrophenyl)-1H-benzimidazole-4-carboxylic acid
3-[(4-chloro-3-methylphenoxy)methyl]-4-ethyl-1H-1,2,4-triazole-5-thione
1-((6-CHLOROPYRIDIN-3-YL)METHYL)PIPERAZINE DIHYDROCHLORIDE
2-Amino-4-[4-(N,N-dimethylsulphamoyl)phenyl]-1,3-thiazole
Ethyl 7-bromo-3,4-dihydroisoquinoline-2(1H)-carboxylate
6-Bromo-4H-spiro[benzo[d][1,3]dioxine-2,4-piperidine]
2-CHLORO-8-ETHYL-5,6,7,8-TETRAHYDRO-5-OXO-PYRIDO(2,3-D)PYRIMIDINE-6-CARBOXYLIC ACID ETHYL ESTER
C12H14ClN3O3 (283.07236439999997)
ETHYL 2-(4-CHLOROPHENYL)-4-HYDROXYTHIAZOLE-5-CARBOXYLATE
C12H10ClNO3S (283.00699000000003)
2-(1,3-benzodioxol-5-yl)-6-nitroimidazo[1,2-a]pyridine
5-TERT-BUTYL-2-(3,4-DICHLORO-PHENYL)-2H-PYRAZOL-3-YLAMINE
5-OXO-6-TRIFLUOROMETHANESULFONYLOXY-1,2,3,5-TETRAHYDROINDOLIZINE
papaveroline
C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent
Ara-G
C10H13N5O5 (283.09166480000005)
D000970 - Antineoplastic Agents 9-β-D-Arabinofuranosylguanine is a Guanosine (HY-N0097) analog and shows high affinity for deoxyguanosine kinase (dGK) with a Km of 8.0 μM. 9-β-D-Arabinofuranosylguanine can be used for the research of T-cell lymphoblastic disease[1][2].
Benzoic acid,2-[[(2-oxo-2-phenylethyl)amino]carbonyl]-
1-Benzenesulfonyl-1H-pyrrolo[2,3-b]pyridine-5-carbonitrile
1-[4-(2-chloro-4-nitrophenyl)piperazin-1-yl]ethanone
C12H14ClN3O3 (283.07236439999997)
3-amino-1-cyclopropyl-6,7-difluoro-8-methoxyquinazoline-2,4-dione
4,7-Dihydro-5H-thieno[2,3-c]pyridine-3,6-dicarboxylic acid 6-tert-butyl ester
2-Chloro-4-morpholinothieno[3,2-d]pyrimidine-6-carbaldehyde
C11H10ClN3O2S (283.01822300000003)
(4-BROMO-2-METHOXYPHENYL)(PYRROLIDIN-1-YL)METHANONE
6-Nitro-4-oxo-8-(trifluoromethyl)-1,4-dihydro-3-quinolinecarbonit rile
2-[(2-METHOXYBENZOYL)AMINO]-4-(METHYLTHIO)BUTANOIC ACID
2-METHANESULFONYL-BIPHENYL-4-YLAMINE HYDROCHLORIDE
1-Cyclopropyl-6,7,8-trifluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
2-(1,1-DIOXIDOTHIOMORPHOLINO)-3-PHENYLPROPANOIC ACID
CIS-1-OXO-SPIRO[CYCLOHEXANE-1,3(1H)-FURO[3,4-C]PYRIDINE]-4-CARBOXYLICACIDHYDROCHLORIDE
6-(TERT-BUTOXYCARBONYL)-4,5,6,7-TETRAHYDROTHIENO[2,3-C]PYRIDINE-2-CARBOXYLIC ACID
2-[(E)-2-(4-Hydrazinophenyl)vinyl]pyridine dihydrochloride
1-ISOPROPYL-1H-BENZOIMIDAZOL-5-YLAMINE TRIHYDROCHLORIDE
(([3-(TRIFLUOROMETHYL)PHENYL]SULFONYL)AMINO)ACETIC ACID
4-([(3-THIENYLMETHYL)AMINO]METHYL)BENZOIC ACID HYDROCHLORIDE
1-[(6-chloro-3-pyridinyl)methyl]piperazine(SALTDATA: 2HCl)
2-(benzyloxycarbonyl)-2-(isopropylthio)acetic acid
4,7-DICHLORO-8-METHYLQUINOLINE-3-CARBOXYLICETHYLESTER
C13H11Cl2NO2 (283.01668060000003)
1-(TOLUENE-4-SULFONYL)-PIPERIDINE-3-CARBOXYLIC ACID
2-(2-Hydroxyphenyl)-1,3-dioxoisoindoline-5-carboxylic acid
Diethyl 6,7-dihydrothieno[3,2-c]pyridine-2,5(4H)-dicarboxylate
5-(3-METHOXYPHENYL)-4-PHENYL-4H-1,2,4-TRIAZOLE-3-THIOL
6-methyl-2-(5-methylthiophen-2-yl)quinoline-4-carboxylic acid
C16H13NO2S (283.06669580000005)
Dexpramipexole (dihydrochloride)
Dexpramipexole dihydrochloride ((R)-Pramipexole dihydrochloride) is a neuroprotective agent and weak non-ergoline dopamine agonist.
(2S,4R)-4-(2-BROMOBENZYL)PYRROLIDINE-2-CARBOXYLIC ACID
(2S,4R)-4-(3-BROMOBENZYL)PYRROLIDINE-2-CARBOXYLIC ACID
(5-CYCLOPROPYL-3-(2,6-DICHLOROPHENYL)ISOXAZOL-4-YL)METHANOL
C13H11Cl2NO2 (283.01668060000003)
o-chlorophenyl o-aminobenzenesulphonate
C12H10ClNO3S (283.00699000000003)
(R)-3-AMINO-4-(4-(TRIFLUOROMETHYL)PHENYL)BUTANOIC ACID HYDROCHLORIDE
Benzenemethanol,3,4-dichloro-a-[[(1-methylethyl)amino]methyl]-,hydrochloride (1:1)
4-CHLORO-7-((2-(TRIMETHYLSILYL)ETHOXY)METHYL)-7H-PYRROLO[2,3-D]PYRIMIDINE
(s)-3-amino-4-(2-trifluoromethylphenyl)butanoic acid hydrochloride
5-TERT-BUTYL-2-(2,6-DICHLORO-PHENYL)-2H-PYRAZOL-3-YLAMINE
5-TERT-BUTYL-2-(2,5-DICHLORO-PHENYL)-2H-PYRAZOL-3-YLAMINE
3-ACETYL-N-(4-CHLOROBENZENESULFONYL)PYRROLE
C12H10ClNO3S (283.00699000000003)
4-(4-METHOXYPHENYL)-5-PHENYL-4H-1,2,4-TRIAZOLE-3-THIOL
Pramipexole dihydrochloride
D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists D020011 - Protective Agents > D000975 - Antioxidants Pramipexole dihydrochloride is a selective and blood-brain barrier (BBB) penetrant dopamine D2-type receptor agonist, with Kis of 2.2 nM, 3.9 nM, 0.5 nM and 1.3 nM for D2-type receptor, D2, D3 and D4 receptors, respectively. Pramipexole dihydrochloride can be used for the research of Parkinson's disease (PD) and restless legs syndrome (RLS)[1][2][3].
(Z)-4-(2-CHLOROBENZYLIDENE)-2-PHENYLOXAZOL-5(4H)-ONE
2-(d-gluco-pentylhydroxypentyl)-4(r)-1,3-thiazolidine-4-carboxylic acid
C9H17NO7S (283.07256920000003)
5-[2-(TOLUENE-4-SULFONYL)-ETHYL]-[1,3,4]THIADIAZOL-2-YLAMINE
(s)-3-amino-4-(4-trifluoromethylphenyl)butanoic acid hydrochloride
Ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide
[3aR-(3aα,6α,7aβ)]-3H-3a,6-methano-2,1-benzisothiazole, 7,7-dichloro-4,5,6,7-tetrahydro-8,8-dimethyl-2,2-dioxide
(R)-Methyl 3-aMino-4-(2,4,5-trifluorophenyl)butanoate hydrochloride
(2S,4R)-4-(4-broMobenzyl)pyrrolidine-2-carboxylic acid
(5,7-dioxo-5,7-dihydro-6H-pyrrolo[3,4-b]pyrazin-6-yl)(phenyl)acetic acid
2-(4-Trifluoromethylphenoxy)pyridine-5-boronic acid
3,4-Dihydroxy-2,5-thiophenedicarboxylic acid 2,5-diethyl ester sodium salt
2-(4-Bromophenyl)-5,8-dioxaspiro[3.4]octan-2-amine
N-(6-chloropyridazin-3-yl)-4-methylbenzenesulfonamide
C11H10ClN3O2S (283.01822300000003)
2-(4-CHLORO-PHENYL)-5-P-TOLYL-2H-PYRAZOL-3-YLAMINE
ETHYL 1-(5-CHLORO-3-FLUOROPYRIDIN-2-YL)-5-METHYL-1H-PYRAZOLE-4-CARBOXYLATE
1-(3-BROMO-5-METHYLPYRIDIN-2-YL)-4-ETHYLPIPERAZINE
1-(4-(5-Bromopyridin-2-yl)piperazin-1-yl)ethanone
C11H14BrN3O (283.03201740000003)
5-(4-METHOXY-PHENYL)-4-PHENYL-4H-[1,2,4]TRIAZOLE-3-THIOL
5-[3-(trifluoromethoxy)phenyl]pyridine-3-carboxylic acid
3-BENZYLOXY-PYRIDINE-2-SULFONYL CHLORIDE
C12H10ClNO3S (283.00699000000003)
6-Benzyl-4-chloro-4,5,6,7-tetrahydro-3H-pyrrolo[3,4-d]pyrimidine hydrochloride
(r)-3-amino-4-(2-trifluoromethylphenyl)butanoic acid hydrochloride
N-(N-P-Nitro-Benzyloxycarbonyl)-Formimidoyl-2-Aminoethylthiol
1-[(4-methylphenyl)sulfonyl]-4-piperidinecarboxylic acid
4-(Methylsulfonamido)-2-(trifluoromethyl)benzoic Acid
3-(4-Chlorophenyl)quinoxaline-5-carboxamide
D000970 - Antineoplastic Agents > D000067856 - Poly(ADP-ribose) Polymerase Inhibitors D004791 - Enzyme Inhibitors
Guanine, 9-beta-D-xylofuranosyl-
C10H13N5O5 (283.09166480000005)
D000970 - Antineoplastic Agents
N-cyclohexyl-2-(2-thienylcarbonyl)-1-hydrazinecarbothioamide
2H-Pyrano[3,2-g]quinolin-2-one, 6,7,8,9-tetrahydro-9-methyl-4-(trifluoromethyl)-
9-Hydroxy-7-methoxy-3,8-dimethylbenzo[g]isoquinoline-5,10-dione
4-(4-Chloroanilino)-3-pyridinesulfonamide
C11H10ClN3O2S (283.01822300000003)
4-[4-(Trifluoromethyl)phenyl]-4,5,6,7-tetrahydrothieno[3,2-c]pyridine
C14H12F3NS (283.06425079999997)
2-[(2-Methylphenyl)methylthio]-5-pyridin-4-yl-1,3,4-oxadiazole
2-[(4-Chlorophenyl)hydrazono]-3-oxo-3-phenylpropanenitrile
N-(2-fluorophenyl)-6-(1,2,4-triazol-1-yl)-3-pyridinecarboxamide
C14H10FN5O (283.08693420000003)
N-[(3-chlorophenyl)methyl]-4-methylphthalazin-1-amine
3-fluoro-N-[3-(1H-tetrazol-5-yl)phenyl]benzamide
C14H10FN5O (283.08693420000003)
N-(5-luoro-4-iminoquinazolin-3-yl)pyridine-4-carboxamide
C14H10FN5O (283.08693420000003)
Dicyclidine
C13H11Cl2NO2 (283.01668060000003)
D016573 - Agrochemicals D010575 - Pesticides
biochanin A(1-)
Conjugate base of biochanin A arising from selective deprotonation of the 7-hydroxy group; major species at pH 7.3.
5-hydroxy-2-(4-methoxyphenyl)-4-oxo-4H-chromen-7-olate
Conjugate base of 5,7-dihydroxy-4-methoxyflavone.
3-[2-(dimethylazaniumyl)ethyl]-1H-indol-4-yl phosphate
C12H16N2O4P- (283.08476459999997)
5-amino-4-chloro-2-(2-oxidomuconoyl)pyridazin-3(2H)-one(2-)
N-acetyl-L-2-aminoadipic acid 6-phosphate
C8H14NO8P (283.04570140000004)
2-amino-9-[5-(hydroxymethyl)-3-sulfanyloxolan-2-yl]-1H-purin-6-one
C10H13N5O3S (283.07390680000003)
2-amino-9-[2,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one
C10H13N5O5 (283.09166480000005)
1-[(2R,5R)-4-Azidooxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione
C10H13N5O5 (283.09166480000005)
2-Amino-9-[(2R,4S,5R)-5-(hydroperoxymethyl)-4-hydroxyoxolan-2-yl]-1H-purin-6-one
C10H13N5O5 (283.09166480000005)
2-Hydroxy-1-methyl-3-phenylsulfanylquinolin-4-one
C16H13NO2S (283.06669580000005)
N-[(2-hydroxyphenyl)-oxomethyl]-2,3-dihydrobenzofuran-5-carboxamide
2-(Methylamino)-6-thiophen-2-yl-4-(trifluoromethyl)-3-pyridinecarbonitrile
Calycosin(1-)
A flavonoid oxoanion obtained by deprotonation of the hydroxy group at position 7 of calycosin. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.).
Wogonin(1-)
The flavonoid oxoanion formed by deprotonation of the 7-hydroxy function of wogonin. Major structure at pH 7.3.
2-[1-(2-Hydroxyanilino)ethylidene]-1-benzothiophen-3-one
C16H13NO2S (283.06669580000005)
2-Ethyl-6-fluoro-7-(1-piperazinyl)-[1,3,4]thiadiazolo[3,2-a]pyrimidin-5-one
Ethyl 2-[2-(2,4-difluorophenyl)-1,3-thiazol-4-yl]acetate
C13H11F2NO2S (283.04785300000003)
6-Methyl-4-(trifluoromethyl)-7,8,9,10-tetrahydropyrano[2,3-f]quinolin-2-one
1-methyl-N-[(E)-thiophen-2-ylmethylideneamino]indole-3-carboxamide
Prunetin-5-olate
A flavonoid oxoanion obtained by deprotonation of the 5-hydroxy group of prunetin. It is the major microspecies at pH 7.3
2-[5-(2-Fluorophenyl)-1,2,4-oxadiazol-3-yl]benzamide
(3S,4S)-5-(6-aminopurin-9-yl)-2-(hydroxymethyl)-4-mercapto-3-oxolanol
C10H13N5O3S (283.07390680000003)
2-[(E)-2-(2-hydroxyphenyl)vinyl]quinolinium chloride
5-[(E)-2-(2,6-difluorophenyl)ethenyl]quinolin-8-ol
(5E)-5-[(1-methyl-1H-pyrrol-2-yl)methylidene]-2-(phenylamino)-1,3-thiazol-4(5H)-one
N-{[3,5-dimethyl-4-(methylthio)phenoxy]carbonyl}-beta-alanine
(Z)-N-(3-Chlorophenyl)-2-cyano-3-pyridin-3-ylprop-2-enamide
(2S,3S,4R,5R)-3,4,5-trihydroxy-6-(pyridine-4-carbonyl)oxane-2-carboxylic acid
Risedronic acid
M - Musculo-skeletal system > M05 - Drugs for treatment of bone diseases > M05B - Drugs affecting bone structure and mineralization > M05BA - Bisphosphonates C78281 - Agent Affecting Musculoskeletal System > C67439 - Bone Resorption Inhibitor D050071 - Bone Density Conservation Agents > D004164 - Diphosphonates D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators
8-hydroxy-2-deoxyguanosine
C10H13N5O5 (283.09166480000005)
8-Hydroxy-2'-deoxyguanosine is a critical biomarker of oxidative stress and carcinogenesis. 8-Hydroxy-2'-deoxyguanosine is a critical biomarker of oxidative stress and carcinogenesis.
psilocybin(1-)
C12H16N2O4P (283.08476459999997)
An organophosphate oxoanion resulting from the protons from the phosphate group and the protonation of the tertiary amino group of psilocybin. The major species at pH 7.3
p-tolyl beta-D-glucuronide(1-)
A carbohydrate acid derivative anion resulting from the removal of a proton from the carboxy group of p-tolyl beta-D-glucuronide.
8-Hydroxyadenosine
C10H13N5O5 (283.09166480000005)
8-Hydroxyadenosine is a purine nucleoside[1].
ALDH1A3-IN-1
ALDH1A3-IN-1 (Compound 14) is a potent ALDH1A3 inhibitor, with an IC50 of 0.63 μM and a Ki of 0.46 μM. ALDH1A3-IN-1 can be studied in prostate cancer[1].
NS3861
NS3861 is an agonist of nicotinic acetylcholine receptors (nAChRs) and binds with high affinity to heteromeric α3β4 nAChR. The binding Ki values of 0.62, 25, 7.8, 55 nM for α3β4, α3β2, α4β4, α4β2, respectively[1].
Varenicline (dihydrochloride)
Varenicline (CP 526555-18) is an orally active partial agonist of α4β2 nicotinic acetylcholine receptor (α4β2 nAChR, IC50 = 250 nM), which is the principal mediator of nicotine dependence. Varenicline is also a partial agonist of α6β2 nAChR and a full agonist of α6β2 nAChR. Varenicline blocks the direct agonist effects of nicotine on nAChR while stimulates nAChR in a more moderate way, being widely used as an aid of smoking cessation[1][2][3][4][5].
5-chloro-3-hydroxy-6-methoxy-1-methyl-3-(2-oxopropyl)indol-2-one
2-{[1-hydroxy-3-(4-hydroxyphenyl)prop-2-en-1-ylidene]amino}benzoic acid
7,8-dimethoxy-4-methylbenzo[g]quinoline-5,10-dione
(2s,3r,4s,5s)-2-(6-hydroxy-2-imino-3h-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
C10H13N5O5 (283.09166480000005)